The FDA's REMS program has been found to have unintentionally created barriers to accessing clozapine, a crucial ...

Nevro Corp. NVRO recently received CE Mark Certification in Europe for its HFX iQ spinal cord stimulation (SCS) system. The ...

BridgeBio Pharma’s acoramidis shows improved survival data, boosting approval chances. Read why BBIO stock could see gains if ...

In a case with national implications, WA’s governor-elect and officials in 18 states are challenging FDA policies that limit ...

Urogen's UGN-102 presents a $5B market opportunity for bladder cancer treatment, despite risks. Read more about URGN stock ...

Generated $50.0 million in net revenue from sales of LUMRYZ™ ----2,300 patients on LUMRYZ as of September 30th, including 700 patients that ...

This certification as well as the Company’s US FDA 510(k) clearance of its revyve™ Antimicrobial Wound Gel will simplify regulatory approval in Australia and New Zealand. Leveraging FB Dermatology’s ...

The tech features a 2mm incision that allows for rapid correction of refractive errors. DND International Eye Hospital has ...

In its quest for a greater global footprint, the company gained GRAS status from the U.S. FDA since 2020 and is Kosher and Halal certified. Samyang has recently quadrupled its annual allulose output ...